End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
25.06 CNY | +0.85% | +3.98% | +7.28% |
Summary
- According to Refinitiv, the company's ESG score for its industry is good.
Strengths
- The prospective high growth for the next fiscal years is among the main assets of the company
- The company's share price in relation to its net book value makes it look relatively cheap.
- Analysts covering this company mostly recommend stock overweighting or purchase.
Weaknesses
- For the last twelve months, sales expectations have been significantly downgraded, which means that less important sales volumes are expected for the current fiscal year over the previous period.
- Revenue estimates are regularly revised downwards for the current and coming years.
Ratings chart - Surperformance
Chart ESG Refinitiv
Sector: Medical Equipment, Supplies & Distribution
1st Jan change | Capi. | Investor Rating | ESG Refinitiv | |
---|---|---|---|---|
+7.28% | 2.24B | - | A- | |
+6.84% | 26.97B | B+ | ||
-40.08% | 2.67B | B- | ||
-19.95% | 2.4B | C+ | ||
+16.30% | 2.28B | B | ||
-13.56% | 1.82B | - | ||
+18.92% | 1.26B | B | ||
-5.27% | 1.21B | - | ||
+20.00% | 1.2B | C | ||
+29.08% | 998M | B- |
Financials
Valuation
Momentum
Consensus
Business Predictability
Environment
Governance
Controversy
Technical analysis
- Stock Market
- Equities
- 300677 Stock
- Ratings Intco Medical Technology Co., Ltd.